
Allegrow Biotech
Allegrow Biotech started in March 2022, as a spinoff start-up from the biomaterials laboratory at the Hong Kong University of Science & Technology.
Our vision is to bring quality and cost-effective cell therapeutic products to the patients. We have a mission to bring together engineers and scientists to innovate and deliver solutions for immune cell engineering to meet the needs of both research and clinical applications.
Our Journey so far
还没有发布任何博客文章。
Powered By
